Cough News and Research

RSS

Common myths about flu from Mayo Clinic

It seems you can't go anywhere these days without hearing "the flu this" or "the flu that." Unfortunately, this season's influenza outbreak is one of the worst in years. And it's not just the flu virus that's causing problems; there are also many myths about the flu that are keeping people from doing more to prevent it.

29 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

Call for more COPD screening for smokers

Screening smokers with spirometry for chronic obstructive pulmonary disease picks up more cases than symptom-based detection, research suggests.

22 Jan 2013

Kaiser Permanente study examines increasing prevalence of undervaccination

In a new study published today in JAMA Pediatrics (formerly Archives of Pediatrics and Adolescent Medicine), Kaiser Permanente researchers found that 49 percent of children ages 2-24 months did not receive all recommended vaccinations or did not get vaccinated according to the Advisory Committee on Immunization Practices schedule.

22 Jan 2013

Rite Aid obtains more than 400,000 additional seasonal flu shots

In response to the nationwide flu epidemic and customer demand, Rite Aid Corporation announced today it has obtained more than 400,000 additional seasonal flu shots, which began arriving in stores earlier this week.

19 Jan 2013

Five flu-prevention tips from Kimberly-Clark Professional

This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).

17 Jan 2013

Underestimating cough duration may skew antibiotic perceptions

US researchers suggest that one reason patients request antibiotics for respiratory infections is that they greatly underestimate how long it usually takes for acute cough illness to resolve.

17 Jan 2013

New menu of 61 genetically engineered E. coli strains may improve efficacy of vaccines

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

17 Jan 2013

Astellas announces FDA acceptance of Tarceva sNDA for EGFR activating mutation-positive NSCLC

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) activating mutations.

17 Jan 2013

Viewpoints: $4,000 a night for a 'cozy' hospital room; Texas effort to provide women's health care falls short

Call it the $55,000 cat bite. That's the rough total in medical costs (so far) for a cat bite on my hand that turned into an infection that turned into surgery that turned into a week in the hospital.

16 Jan 2013

Monitor white blood cell count in pertussis infants

Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.

14 Jan 2013

Boston declares flu emergency as aggressive viruses spread across the nation

The country is in the grip of three emerging flu or flulike epidemics: an early start to the annual flu season with an unusually aggressive virus, a surge in a new type of norovirus, and the worst whooping cough outbreak in 60 years. And these are all developing amid the normal winter highs for the many viruses that cause symptoms on the "colds and flu" spectrum.

11 Jan 2013

Taking early and repeated WBC is critical in determining infants at high risk of pertussis

A study released today from the upcoming issue of the Journal of the Pediatric Infectious Diseases Society (JPIDS) found that taking early and repeated white blood cell counts (WBC) is critical in determining whether infants have pertussis and which of those children are at highest risk of death from the disease.

11 Jan 2013

Tips for parents to safely help relieve child's flu symptoms

Doctors' offices are teeming with patients suffering from one of the worst outbreaks of cold and flu season in recent years. The Centers for Disease Control and Prevention has said that flu is at an elevated level across the nation. Though virus symptoms vary by age, children are especially vulnerable since they are unable to take over-the-counter medications to help alleviate symptoms.

10 Jan 2013

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.

3 Jan 2013

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

2 Jan 2013

Antibiotics do not help lower-respiratory tract infections

The antibiotic amoxicillin fares no better at reducing symptoms in patients with lower-respiratory tract infections than a placebo drug, indicate data from a dozen European countries.

28 Dec 2012

Antibiotic amoxicillin ineffective for treating cough according to European trial

The antibiotic amoxicillin, that doctors typically prescribe for common lower respiratory tract infections (LRTI) such as cough and bronchitis, is no more effective at relieving symptoms than the use of no medication, even in older patients. The findings from the largest randomised placebo controlled trial of antibiotics for acute uncomplicated LRTI to date are published Online First in The Lancet Infectious Diseases.

20 Dec 2012

NIDA's 2012 Monitoring the Future survey shows rates stable or down for most drugs

Continued high use of marijuana by the nation's eighth, 10th and 12th graders combined with a drop in perceptions of its potential harms was revealed in this year's Monitoring the Future survey, an annual survey of eighth, 10th, and 12th-graders conducted by researchers at the University of Michigan.

20 Dec 2012

EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III STARTa trial of its investigational product L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced stage IIIA or IIIB non-small cell lung cancer (NSCLC) did not meet its primary endpoint to demonstrate a statistically significant improvement in overall survival (OS).

19 Dec 2012

Cough News and Research

Common myths about flu from Mayo Clinic

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Call for more COPD screening for smokers

Kaiser Permanente study examines increasing prevalence of undervaccination

Rite Aid obtains more than 400,000 additional seasonal flu shots

Five flu-prevention tips from Kimberly-Clark Professional

Underestimating cough duration may skew antibiotic perceptions

New menu of 61 genetically engineered E. coli strains may improve efficacy of vaccines

Astellas announces FDA acceptance of Tarceva sNDA for EGFR activating mutation-positive NSCLC

Viewpoints: $4,000 a night for a 'cozy' hospital room; Texas effort to provide women's health care falls short

Monitor white blood cell count in pertussis infants

Boston declares flu emergency as aggressive viruses spread across the nation

Taking early and repeated WBC is critical in determining infants at high risk of pertussis

Tips for parents to safely help relieve child's flu symptoms

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Antibiotics do not help lower-respiratory tract infections

Antibiotic amoxicillin ineffective for treating cough according to European trial

NIDA's 2012 Monitoring the Future survey shows rates stable or down for most drugs

EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News